David Xie is currently a second year MBA student at MIT Sloan
School of Management. Previously, he had 6 years of experience
in the development and commercialization of DNA sequencing
technologies and their applications in the diagnostics and
drug screening markets.
Prior to Sloan, David worked with Arch Venture Partners to
build Transfigure Medicine, a seed-stage company through a
combination of capital raising and business development. As a
research scientist at Helicos BioSciences since its inception,
he conducted research that helped to improve the read length,
accuracy and throughput of the Single Molecule DNA Sequencing
David has a PhD in Biophysics from the University of Chicago,
and a BS in Chemistry from Peking University.
Andrea is a second year Systems Design & Management Fellow at
MIT, where she is pursuing her Masters of Science in
Engineering and Management. She also serves as a Research
Assistant at the Lean Advancement Initiative, where her
research is focused on assessing the role of technology
extended outside of the clinic to better improve access to
care for service members in the Military Health System. Prior
to MIT, she worked as a Research Scientist within the
Corporate Technology Development group at Boston Scientific
Corporation. She obtained both her B.S in Biological
Engineering in 2006 and Masters of Engineering in Biomedical
Engineering in 2007 from Cornell University.
Sandra is a second year MBA student at the MIT Sloan School of
Management. Prior to attending MIT Sloan, she was a
Pharmaceuticals Analyst at Decision Resources where she
specialized in Psychiatry and Pain, helping clients to
understand market dynamics and opportunities through
syndicated market research reports and forecasts. She spent
four years studying axon regeneration in Harvard Medical
School's Biological Biomedical Sciences (BBS) Doctorate
program. Sandra received her M.S. in Biomedical Sciences from
Harvard and B.S. in Biology, with Minors in Music and Brain
and Cognitive Sciences, from MIT. Over the past summer, Sandra
worked as a Johnson & Johnson Strategic Marketing Intern.
Eliza is a second year MBA student at the MIT Sloan School of
Management. Prior to attending MIT Sloan, Eliza was an
Associate in the consulting group of Leerink Swann, developing
growth opportunities for biopharmaceutical clients through
optimization of internal drug portfolios, assessment of
external opportunities, and assistance with overall R&D;
strategy to enhance company value. Before Leerink Swann, she
worked at UK Trade & Investment, helping early stage life
science companies in the UK with their market entry strategy
into the United States. For the summer, Eliza worked at Smith
& Nephew, a leading medical device company, as a marketing
intern in the Gynecology group. Eliza earned a B.A. and M.A.
in Biochemistry and Molecular Biology, summa cum laude, from
Serena is a second year MBA student at the MIT Sloan School of
Management. Prior to MIT Sloan, she spent 4 years working in
the biopharmaceutical industry in Boston as a scientist and
project manager. In her professional career, she has had a
wide array of experiences in drug discovery, development and
manufacture. During the summer, she worked for Northern Light
Venture Capital, a leading VC with $700M AUM in China as an
investment associate in healthcare and Macquarie Securities
Group, a leading global investment bank as an Equity Analyst
covering China Healthcare Sector. Serena earned her B.E in
Chemistry from Shanghai Jiaotong University in China and
M.A. in Biophysics from SUNY Buffalo in US.
Jonathan is a first year MBA student at the MIT Sloan School
of Management. Prior to Sloan, Jonathan worked as the Director
of Medical Affairs for Covidien. He completed residency in
anesthesia at the Massachusetts General Hospital and presently
holds a faculty appointment as Clinical Instructor at the
University of Pittsburgh School of Medicine. Prior to this he
researched drug metabolism at the Scripps Research Institute's
Department of Molecular and Experimental Medicine. He is a
Diplomate of the American Board of Anesthesiology and the
author of over 20 peer-reviewed publications.
Lydia is a first year MBA student at the MIT Sloan School of
Management. Prior to MIT Sloan, she worked in energy and
healthcare. Her most recent job was at the University of
Maryland Medical System where she facilitated a lean
implementation on a medical unit. Lydia is a graduate of the
University of Pennsylvania where she received a BSc in Systems
Engineering and a BA in Economics.
Lauren Ankeles is a first-year MBA student at the MIT Sloan
School of Management. Prior to joining MIT Sloan, Lauren
worked as a Senior Product Manager in Marketing Strategy for
Boston Scientific, a medical device manufacturer. She focused
primarily on Boston Scientific's Cardiac Rhythm Management
division. Before Boston Scientific, Lauren was a consultant
with the Monitor Group. Lauren earned a Bachelor's of Science
in Economics, cum laude, from the Wharton School at the
University of Pennsylvania, concentrating in Healthcare
Management and Operations and Information Management.
Sheridan is a first year MBA student at the MIT Sloan School
of Management. She is a former Senior Associate at Triage
Consulting Group, where she analyzed managed care
reimbursement structures and provided revenue maximization
recommendations for urban hospitals. Prior to Triage, Sheridan
worked as a Special Events Recruiter for American Cancer
Society while earning a BS in Biology and a BA in Economics,
magna cum laude, from the University of California, San Diego.
Simon is a first year MBA student at the MIT Sloan School of
Management. Prior to MIT Sloan, he worked as a consultant for
Exeter Group, a Cambridge based IT consulting firm. His
projects included IT strategy and system implementation in the
healthcare and higher education industry. Simon is a graduate
of Harvard College where he received a B.A in Economics.
Juha is a first year MBA student at the MIT Sloan School of
Management. Prior to Sloan, Juha worked as a management
consultant at Accenture, specializing on Life Sciences
Strategy. Juha has conducted nearly five years of research at
Yale School of Medicine and authored over ten primary research
articles in scientific journals, including Nature and Neuron.
Erik Tautkus is a first-year MBA student at the MIT Sloan
School of Management. Prior to Sloan, Erik worked at
Cornerstone Research, an economic consulting firm. His work
focused on analyzing the economic and financial issues in
anti-trust and intellectual property corporate litigation.
Erik worked on pharmaceutical cases involving patent
infringement, off-label marketing and efficacy
misrepresentation. Erik graduated from the Ivey School of
Business at the University of Western Ontario with an Honors
in Business Administration.
Isa Watson is a first-year MBA student at the MIT Sloan School
of Management. Prior to Sloan, Isa worked as a biomedical
researcher in both academia and industry. She has also worked
in Clinical Development at Pfizer, where her work focused on
revising clinical strategies for their global pain program.
Isa earned an MS in Pharmacology from Cornell University and a
BS in Chemistry from Hampton University.
Ying-Yu Chen is a first-year MBA student at the MIT Sloan
School of Management. Before Sloan, Ying-Yu was a co-founder
of Hersheywife, an online retailer providing international
purchasing service for consumers in Taiwan. Before
Hersheywife, she was the chief physician at 104 Cosmetic
Clinic, where she designed and operated physician coaching
program and was identified by customers as the most valuable
physician. Prior to 104 Cosmetic Clinic, she was an OB/GYN
resident physician at National Taiwan University Hospital,
where she earned the title
Best Intern of the Year
obtained her MD degree in National Taiwan University and was
involved in providing accurate update to the public during
Stephanie Lichtinger is a first-year MBA student at the MIT
Sloan School of Management. Prior to Sloan, Stephanie worked
as a Business Analyst at McKinsey & Co, where she specialized
in Pharmaceuticals and Healthcare. The clients she served
included large and small pharmaceutical and healthcare
companies in the U.S., Japan and Latin America, with project
ranging from growth strategy to product launch. Stephanie
earned a BA from the University of Pennsylvania.
Nishanth is a first-year Leaders for Global Operations (LGO)
Fellow at MIT, where he is pursuing an MBA and a Masters of
Science in Engineering Systems. Prior to MIT, he worked as a
manufacturing engineer at Amgen Inc., the world's largest
biotechnology company, supporting Clinical Operations.
Nishanth received his B.S. in Mechanical Engineering from Duke
University in 2007.
Eric Khairy is an MBA student in the MIT Sloan Fellows Program
in Innovation and Global Leadership. Prior to attending MIT
Sloan, Eric was the Director of the Surgical Robotics Division
at Minogue Medical Inc., where he led a national team of
clinical specialists and field engineers, and designed and
implemented product training protocols for surgeons, nurses,
and account managers. Before Minogue Medical, he was a product
development engineer in the general-purpose DSP division at
Analog Devices Inc. Eric earned a B.Eng. in computer
engineering from McGill University and an M.A.Sc. in
biomedical engineering from Universite de Montreal.
Lamees is a second year MBA student at the MIT Sloan School of
Management. Prior to MIT Sloan, Lamees worked in human
resources at Pacific Alternative Asset Management Company.
Over the summer, she worked at Daktari Diagnostics doing
market analysis and strategy. Lamees is a graduate of UC
Irvine, where she received her Bachelor's degree in Sociology.
Elana Shapiro is a first-year MBA student at the MIT Sloan
School of Management. Prior to Sloan, Elana worked as an
Account Supervisor at Cohn & Wolfe, a public relations agency,
where she helped develop and implement PR programs for
pharmaceutical and biotechnology companies. At Cohn & Wolfe,
she focused primarily on oncology and neurology projects.
Elana graduated from Brown University with a BA in psychology.
Lindsay is a first-year MBA student at the MIT Sloan School of
Management. Prior to Sloan, Lindsay worked on the Marketing
team in the fundraising office at Dana-Farber Cancer Institute
and the Jimmy Fund, where she was responsible for developing
marketing strategy for several of Dana-Farber's fundraising
programs and events. Lindsay graduated from Wake Forest
University with a BA in Communications.
Jordy is a first year MBA student at the MIT Sloan School of
Management. Prior to attending Sloan, he was a process
development engineer in the cell culture group at Pfizer
(formerly Wyeth). His work focused on optimizing mammalian
cell culture processes for projects in multiple indications,
including hemophilia and Alzheimer's disease. Jordy graduated
from Tufts University with a M.S. in biotechnology engineering
and a B.S. in chemical engineering.
Freida is a second year MBA student at MIT Sloan. She
graduated summa cum laude from Sewanee, The University of the
South with a BA in Economics. Prior to MIT Sloan, she worked
at PricewaterhouseCoopers in New York as an Economic
Consultant in Transfer Pricing. She has always had an interest
in Healthcare especially delivering healthcare in developing
countries. In March 2011, as part of MIT's Global Health Care
delivery class, she worked with Doctors from Massachusetts
General Hospital (MGH) to develop a viable business to fund
an HIV family clinic in Uganda.
Yvonne is a second year MBA student at MIT Sloan. Before
business school, she worked on M&A; and corporate strategy at
Morgan Stanley's Firm Strategy and Execution group in New
York. This past summer, she did a management consulting
internship with Bain in Boston. She obtained her bachelor's
degree from Yale University in Biology and Economics.
Omid is currently a MBA candidate at MITSloan. Prior to
MITSloan Omid functioned as a software engineer and project
manager at distinct biotech related groups. He worked at the
Department of Energy's Joint Genome Institute, as the first
employee of a VC-funded proteomics startup, and other similar
firms where technology and biology overlap. In 2006, Omid
graduated from UC Berkeley with a BS in Biological
Engineering, with a focus in Bioinformatics and Computer